Scancell Share Discussion Threads

[wigwammer] 16/10/2017 16:26

You sound very silly. "The Astute know when to buy."I'm afraid there is no proof of that.

[terror] 16/10/2017 16:12

No. Just addressing the first one to you as I wasn’t convinced you had the intelligence to Work that out.

Turns out that was an Astute move by me.

[wigwammer] 16/10/2017 16:04

The point that you went back and changed your message demonstrates a little insecurity.Both versions were utterly hilarious though ;)

[terror] 16/10/2017 15:54

Wigwammer - How was my Red Indian greeting. I didnt want to know that you had purchased at 10.5p, so by that revelation, you are not Astute.

[chelsea35] 16/10/2017 15:44

Wigwammer agree. All after the event.

[wigwammer] 16/10/2017 15:44

I can detail the posts where I made initial purchase at circa 10.5p.Does that demonstrate I am astute?

[terror] 16/10/2017 15:31

Wigwammer -How!

[wigwammer] 16/10/2017 15:20

"The Astute know when to buy."I'm afraid there is no proof of that.

[terror] 16/10/2017 14:36

The Astute know when to buy.

The current trades indicate that sellers are still out there holding the share price back.

Just a case of clearing out the backlog before it steps up. The share price still needs a partnership and clear funding agreement before it will move significantly higher.

All IMHO

[chelsea35] 16/10/2017 14:22

That view was expressed by one person. I trust the ASTUTE loaded up at 10p and 12p??

[the real lozan] 16/10/2017 13:52

Just for BALANCE and clarification -
"but seeing all posts over last few years and some views are very inflexible. Why?"
If, as *WE* CAN clearly see, those "views" that have been PROVEN to have been ACCURATE, one might ask - do they NEED to have been "flexible" ???
or
Do those "views" that have been 100% INACCURATE, and sooo costly to those who 'blindly' followed them, insisting folks to ignore / exclude any 'Alternative Views' ... are those PROVEN INACCURATE "views" the "views" that are the "very inflexible" ones ???
You know, the "views" like = "NO RISK here" or "FUNDING is NOT an ISSUE HERE" ETC. ETC.
At least some are prepared to now accept that "Sure there are risks in anything"

[chelsea35] 16/10/2017 11:12

Thanks Loz, I was a bit concerned about yours to be honest.

[inxsight] 16/10/2017 11:12

My researching as above was also going through 5 years of regulatory news to form my view. Sure there are risks in anything but seeing all posts over last few years and some views are very inflexible. Why?

[the real lozan] 16/10/2017 10:10

Elsie -
Your distress is understandable

[chelsea35] 16/10/2017 09:59

Lozan..........A downwards trend and a falling share price has always been good enough for you to suggest our troubles are very real. An upward trend with 450k buys today brings possible doubt. Seems to be a growing demand from non CONtributors. Just a thought.......

[the real lozan] 16/10/2017 09:01

Just a thought -
The 'pop-u-lar' CON viction here has morphed into the belief that 'a game changer' is "On the Cards" between now and the 'take-over' in January next year...
All sounds good.... if this proves to be so.
However
What would the 'pop-u-lar' mood be, if - nothing of a 'game-changer' appears, between now and January next year ???
Could such a theory possibly become a REALITY ???
Just a thought -

[bermudashorts] 15/10/2017 20:01

Have been looking into another stock and came across the following research into citrullination which was carried out by Medimmune (AstraZeneca). The paper was published at the end of September in the peer-reviewed journal, Frontiers in Immunology.

While it's quiet I thought it may be of interest to some here - if nothing else it shows that Scancell are operating in an area which is attracting more and more attention. Indeed LD's research is cited in the paper.

hxxps://www.frontiersin.org/articles/10.3389/fimmu.2017.01200/full

[inxsight] 15/10/2017 13:53

Hi everyone. I posted a few weeks back for views and thanks for the mention of the Hardman report which I read and was good to see. I looked back at this board to find what was plus and minus points as members see it. Sure there is a lot of progress over the last few years and the problem of funds but what they have raised has been well managed. Made it to the AGM as I had a space in the diary. Seems a lot is going on and to see management at AGM was good after reading up on the companys last five years in a few weeks. Maybe in the next three months things will move forward a lot. I rate this as worth buying now.

[chelsea35] 15/10/2017 10:44

miovace, wouldn"t worry about it if i were you. Nothing wrong with your attitude, the only problem agema would have is your very positive take on the share. A 14% rise last week suggests you are far from alone.

[miavoce] 15/10/2017 09:40

Hi agema

I have no problem with different views, it is just the aggressive / argumentative tone displayed by a number of posters which deters me.

Best regards.

[agema] 15/10/2017 08:25

miavoce

I can see why you don't post very often. Because you don't like it if anyone has a different view or ideas to you. Hence your last sarcastic post.

Probably a good idea that you don't post very often with that attitude.

[wanderer1210_0] 14/10/2017 19:10

RG told them years ago the moon was made of green cheese and they all believed it. Can't say I've noticed it myself but if you look just to the right of the iron chickens nest you'll see baby clanger playing with the soup dragon.

[chelsea35] 14/10/2017 18:11

miavoce, my thoughts entirely. Some still have a different opinion though. I have been to three AGMs 2013/14/16, unfortunately couldn"t attend this year, but the recording of the AGM, which i have listened to on three occasions now certainly IMHO suggested what you say could well be the case. Hoping so too for RG before his tenure ends. I rather think the timing of it augers well for good news too.

agema, fair point, but i do think recruitment for the Combo Trial is in very capable hands. That being the case a trial start date beginning in March will do us no harm. Further, funding news, IND Approval and confirmation of trial beginning historically has a very positive effect on the share price I see no reason why that will not be the case for us this time, and of course for momentum news of the Moditope Trial should not be all that far off. Early immune responses from the Combo Trial will add to the excitement which we have been so lacking in recent times.